Data / Form D filings / Pharminex, L.L.C.
Pharminex, L.L.C.: Form D filings
Pharminex, L.L.C., a pharmaceuticals company in Williamsville, NY, filed 4 Form D notices with the SEC between 2010 and 2013. The latest, on January 24, 2013, reports $3.1 million sold of a $3.1 million offering to 38 investors.
Find out what Pharminex, L.L.C. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6467 MAIN STREET, Williamsville, NY, 14221
- Phone
- (716) 650-6107
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- New York
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1488333
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 24, 2013 | New notice | $3,147,857 | $3,147,857 | $0 | 38 | Dec 31, 2012 | sec.gov |
| Apr 18, 2011 | Amendment | $5,000,000 | $4,134,572 | $865,428 | 64 | Dec 30, 2010 | sec.gov |
| Feb 15, 2011 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 19 | Dec 30, 2010 | sec.gov |
| Apr 6, 2010 | New notice | $4,025,000 | $4,025,000 | $0 | 60 | Feb 29, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles E Lannon | Executive Officer, Director | |
| John E Bellomo | Executive Officer, Director | |
| Jonathan E Swiatkowski | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jan 21, 2013 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pharminex, L.L.C. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.